Ayer Capital Management

Ayer Capital Management as of June 30, 2012

Portfolio Holdings for Ayer Capital Management

Ayer Capital Management holds 31 positions in its portfolio as reported in the June 2012 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Teva Pharmaceutical Industries (TEVA) 10.4 $23M 581k 39.44
Grifols S A 6.9 $15M 1.6M 9.60
Alere 6.2 $14M 704k 19.44
ArthroCare Corporation 6.1 $14M 460k 29.28
Idenix Pharmaceuticals 5.7 $13M 1.2M 10.30
Intermune cv 5.0% 5.5 $12M 11M 1.08
Dynavax Technologies Corporation 5.1 $11M 2.6M 4.32
Oncothyreon 4.8 $11M 2.3M 4.68
Ariad Pharmaceuticals 4.8 $11M 609k 17.21
Celgene Corporation 4.2 $9.3M 145k 64.16
Cardinal Health (CAH) 4.1 $8.9M 213k 42.00
McKesson Corporation (MCK) 4.0 $8.8M 94k 93.76
SciClone Pharmaceuticals 4.0 $8.8M 1.3M 7.01
CIGNA Corporation 3.8 $8.3M 188k 44.00
NPS Pharmaceuticals 3.8 $8.2M 955k 8.61
Dendreon Corp cnv 3.2 $7.0M 6.2M 1.13
Sanofi-Aventis SA (SNY) 2.3 $5.0M 133k 37.78
Chemocentryx 2.3 $5.0M 334k 15.00
Hologic (HOLX) 1.9 $4.2M 231k 18.04
Threshold Pharmaceuticals 1.7 $3.7M 505k 7.40
Sucampo Pharmaceuticals 1.5 $3.3M 463k 7.03
BioSpecifics Technologies 1.2 $2.7M 142k 18.78
Ligand Pharmaceuticals In (LGND) 1.2 $2.6M 151k 16.94
Biolinerx Ltd-spons 1.2 $2.6M 1.1M 2.44
Biomira Inc Cmn Stock cmn 1.0 $2.3M 489k 4.68
Omeros Corporation (OMER) 1.0 $2.3M 225k 10.00
Ym Biosciences 0.7 $1.5M 750k 1.98
WellPoint 0.6 $1.2M 19k 63.78
Celgene Corp right 12/31/2011 0.5 $1.1M 602k 1.88
Cyclacel Pharmaceuticals 0.3 $571k 1.5M 0.37
Palatin Technologies 0.0 $47k 93k 0.50